β-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck

Clinical Cancer Research

Volumn 11, Issue 7, 2005, Pages 2471-2477

  Yu, Ziwei ^a   Weinberger, Paul M ^a   Provost, Elayne ^a   Haffty, Bruce G ^a   Sasaki, Clarence ^a   Joe, J ^a   Camp, R L ^a   Rimm, D L ^a   Psyrri, Amanda ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; CYCLIN D1;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; MUTATION; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

ADULT; AGED; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CYCLIN D1; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; SURVIVAL ANALYSIS; TRANS-ACTIVATORS;

EID: 17644410390     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-2199     Document Type: Article

References (42)

1. Al-Sarraf M. Treatment of locally advanced head and neck cancer: historical and critical review. Cancer Control 2002;9:387-99.
2. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91.
3. Nagafuchi A. Molecular architecture of adherens junctions. Curr Opin Cell Biol 2001;13:600-3.
4. Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002;4:101-8.
5. Gumbiner BM. Regulation of cadherin adhesive activity. J Cell Biol 2000;148:399-404.
6. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
7. Cadigan KM, Nusse R. Wnt signaling: a common theme in animal development. Genes Dev 1997;11:3286-305.
8. Provost E, Yamamoto Y, Lizardi I, et al. Functional correlates of mutations in β-catenin exon 3 phosphorylation sites. J Biol Chem 2003;278:31781-9.
9. Tateishi K, Omata M, Tanaka K, Chiba T. The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J Cell Biol 2001;155:571-9.
10. Eger A, Stockinger A, Schaffhauser B, Beug H, Foisner R. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of β-catenin and upregulation of β-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J Cell Biol 2000;148:173-88.
11. Yu Z, Weinberger PM, Haffty BG, et al. Cyclin D1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res. In press 2005;11:1180-6.
12. Camp RL, Chung GG, Rimm DL. Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 2002;8:1323-7.
13. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-35.
14. Camp RL, Dolled-Filhart M, Rimm DL. X-Tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. In press 2004;10:7252-9.
15. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992;48:73-85.
16. Miller R, Siegmund D. Maximally selected Chi-square statistics. Biometrics 1982;38:1011-6.
17. Takaishi K, Sasaki T, Kotani H, Nishioka H, Takai Y. Regulation of cell-cell adhesion by rac and rho small G proteins in MDCK cells. J Cell Biol 1997;139:1047-59.
18. Braga VM, Machesky LM, Hall A, Hotchin NA. The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol 1997;137:1421-31.
19. Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Ferreira VM, Lopes CS. Association of E-cadherin and β-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas. Hum Pathol 2004;35:663-9.
20. Choi YS, Shim YM, Kim SH, et al. Prognostic significance of E-cadherin and β-catenin in resected stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2003;24:441-9.
21. Bremnes RM, Veve R, Gabrielson E, et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002;20:2417-28.
22. Maelandsmo GM, Holm R, Nesland JM, Fodstad O, Florenes VA. Reduced β-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma. Clin Cancer Res 2003;9:3383-8.
23. Imura J, Ichikawa K, Takeda J, Fujimori T. β-catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med 2001;8:353-8.
24. Yoshida R, Kimura N, Harada Y, Ohuchi N. The loss of E-cadherin, α- and β-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int J Oncol 2001;18:513-20.
25. Garcia del Muro X, Torregrosa A, Munoz J, et al. Prognostic value of the expression of E-cadherin and β-catenin in bladder cancer. Eur J Cancer 2000;36:357-62.
26. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, Tsao SW. Downregulation and abnormal expression of E-cadherin and β-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Hum Pathol 1999;30:458-66.
27. Nhieu JT, Renard CA, Wei Y, Cherqui D, Zafrani ES, Buendia MA. Nuclear accumulation of mutated β-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am J Pathol 1999;155:703-10.
28. Mizushima T, Nakagawa H, Kamberov YG, Wilder EL, Klein PS, Rustgi AK. Wnt-1 but not epidermal growth factor induces β-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Cancer Res 2002;62:277-82.
29. Park WS, Oh RR, Park JY, et al. Nuclear localization of β-catenin is an important prognostic factor in hepatoblastoma. J Pathol 2001;193:483-90.
30. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G. β-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 2001;158:987-96.
31. Brennan KR, Brown AM. Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 2004;9:119-31.
32. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000;103:311-20.
33. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997;275:1790-2.
34. de La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 1998;95:8847-51.
35. Takei S, Ueno Y, Yoda J, et al. Roles of β-catenin overexpression and adenomatous polyposis coli mutation in head and neck cancer. Nippon Jibiinkoka Gakkai Kaiho 2003;106:692-9.
36. Gonzalez MV, Pello MF, Ablanedo P, Suarez C, Alvarez V, Goto E. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and β-cat genes in squamous cell carcinoma of the head and neck. J Clin Pathol 1998;51:520-4.
37. Bankfalvi A, Krassort M, Vegh A, Felszeghy E, Piffko J. Deranged expression of the E-cadherin/β-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 2002;31:450-7.
38. Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M. Expression of E-cadherin, α-catenin, and β-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 2003;89:557-63.
39. Gasparoni A, Chaves A, Fonzi L, Johnson GK, Schneider GB, Squier CA. Subcellular localization of β-catenin in malignant cell lines and squamous cell carcinomas of the oral cavity. J Oral Pathol Med 2002;31:385-94.
40. Lopez-Gonzalez JS, Cristerna-Sanchez L, Vazquez-Manriquez ME, Jimenez-Orci G, Aguilar-Cazares D. Localization and level of expression of β-catenin in human laryngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2004;130:89-93.
41. Kudo Y, Kitajima S, Ogawa I, et al. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous β-catenin. Clin Cancer Res 2004;10:5455-63.
42. Pukkila MJ, Virtaniemi JA, Kumpulainen EJ, et al. Nuclear β-catenin expression is related to unfavourable outcome in oropharyngeal and hypopharyngeal squamous cell carcinoma. J Clin Pathol 2001;54:42-7.